AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypesMinke A.E. Rab, Richard van Wijk, Kendall Johnson et al.|Haematologica|2020Cited by 81
Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK StudyRachael F. Grace, Bertil Glader, Christian Rosé et al.|Blood|2016Cited by 6